arrow
T

Tsz Yu Chow

The Chinese University of Hong Kong
H指数:9
被引数:247

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study

免疫抑制患者中早期SARS-CoV-2病毒反弹与长COVID状况的关联:队列研究

2026-04-070
PRE
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study

奈玛特韦/利托那韦和莫诺拉韦对老年人群后COVID糖尿病风险的有效性:一项目标试验模拟研究

2026-03-170
OAAI
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

Nirmatrelvir-ritonavir立即开始治疗对COVID后结果的更大益处: 一项基于人群的回顾性队列研究

2025-11-100
OAAI
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study

新型冠状病毒肺炎患者的SARS-CoV-2反弹和急性后死亡率和住院: 队列研究

2025-07-280
OAAI
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study

哮喘患者中尼玛特雷韦/利托那韦与莫诺拉韦的短期和长期比较疗效:一项队列研究

2025-02-280
OA
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation

nirmatrelvir/ritonavir和molnupiravir对门诊患者的post-COVID-19结果的有效性: 目标试验仿真研究

2025-02-180
OAAI
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study

新型冠状病毒肺炎疫苗接种改善尼马瑞韦-利托那韦对急性后死亡率和再住院的影响: 一项回顾性队列研究

2024-11-040
OAAI
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

尼马曲韦-利托那韦与新型冠状病毒肺炎住院患者急性后遗症和死亡率的关系: 一项回顾性队列研究

2024-10-014
OAAI
Association between asthma and COVID-19 severity during Omicron epidemic: a retrospective cohort study using real-world data

Omicron流行期间哮喘与新型冠状病毒肺炎严重程度之间的关系: 一项使用真实数据的回顾性队列研究

2024-07-042
OAAI